Patents by Inventor Simon E Aspland

Simon E Aspland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-10 carbamates of taxanes
    Patent number: 8138361
    Abstract: Provided herein are C-10 taxane carbamates and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating cancer and taupathy.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: March 20, 2012
    Assignees: The Trustees Of The University Of Pennsylvania, Acidophil, LLC
    Inventors: Carlo Ballatore, Angelo J Castellino, Amos B Smith, III, Joel Desharnais, Chengzao Sun, Simon E Aspland
  • COMPOSITIONS AND METHODS OF TREATING ENDOTHELIAL DISORDERS
    Publication number: 20120065165
    Abstract: Compositions and methods of treating endothelial disorders, including: asthma, erectile dysfunction, pulmonary hypertension, cardiovascular disorders, and other disorders, using a synergistic combination of at least one arginase inhibitor and at least one phosphodiesterase (PDE1), (PDE2) and/or (PDE5) inhibitor are described.
    Type: Application
    Filed: November 2, 2009
    Publication date: March 15, 2012
    Applicant: ARGINETIX, INC
    Inventors: Simon E. Aspland, Dan E. Berkowitz, Trinity Bivalacqua, Hunter Champion
  • C-10 CARBAMATES OF TAXANES
    Publication number: 20090306014
    Abstract: Provided herein are C-10 taxane carbamates and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating cancer and taupathy.
    Type: Application
    Filed: December 27, 2006
    Publication date: December 10, 2009
    Applicants: Acidophil llc, The Trustees of the University of Pennsylvania
    Inventors: Carlo Ballatore, Angelo J. Castellino, Amos B. Smith, III, Joel Desharnais, Chengzao Sun, Simon E. Aspland